Cost-effectiveness of mechanical thrombectomy versus intravenous thrombolysis in acute ischemic stroke: a systematic review [0.03%]
急性缺血性卒中患者机械取栓与静脉溶栓治疗效果比较的系统综述
Nasim Jaberi,Mohammad Alimoradnori,Aghdas Souresrafil et al.
Nasim Jaberi et al.
Introduction: Mechanical thrombectomy (MT) is a proven treatment for acute ischemic stroke (AIS), yet its cost-effectiveness across global settings remains unclear. This systematic review synthesizes cost-effectiveness ev...
The role of patient-reported outcomes in health technology assessments: global practices and future implications [0.03%]
患者报告结果在卫生技术评估中的作用：全球实践及对未来的影响
Nenad Medic,James Ryan,Calvin N Ho et al.
Nenad Medic et al.
Background: Patient-reported outcome (PRO) data capture patients' perspectives on their disease and its treatments; however, use of such data in health technology assessments (HTA) and pricing/reimbursement processes is l...
Francisco Santos-Gonzalez,Ellenore Martin,Madeleine Harris et al.
Francisco Santos-Gonzalez et al.
Background: Functional genomics approaches, such as transcriptomics and proteomics, can provide valuable insights into rare diseases when genomic sequencing fails to yield informative findings. This study estimated the mo...
Conceptualization of a decision-analytic model in youth mental health: an application of stakeholder engagement in model development in the Netherlands [0.03%]
在荷兰利用利益相关者参与法进行模型开发的概念化——青年精神健康的决策分析模型应用举例
Hendrika J Valkenburg,Maartje Vriens,Dwayne Meijnckens et al.
Hendrika J Valkenburg et al.
Background: The long-term impact of preventive policies in the Netherlands on the mental health of young adults remains unclear. Therefore, this paper describes the development of a conceptual model of youth mental health...
Cost per responder analysis of lebrikizumab versus tralokinumab in moderate to severe atopic dermatitis from a United States perspective [0.03%]
从美国视角看勒布里库单抗与曲拉西珠单抗治疗中重度特应性皮炎的每响应者成本分析
Meichen Yu,Jiahao Li,Ruxin Zhang et al.
Meichen Yu et al.
Background: Lebrikizumab and tralokinumab significantly treat moderate-to-severe atopic dermatitis. Nevertheless, pharmacoeconomic analyses and head-to-head clinical studies for both are lacking. This study aimed to compa...
The economic impact, healthcare resource utilization, and clinical outcome over 24 months in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece- the fidelity study [0.03%]
希腊复发缓解型多发性硬化症患者使用富马酸二甲酯治疗的24个月内的经济影响、医疗资源利用和临床转归：Fidelity研究
Georgia Kourlaba,Georgios Koutsis,Nikolaos Fakas et al.
Georgia Kourlaba et al.
Background: The review of healthcare costs in multiple sclerosis (MS) has been of increased interest. In this study, we aimed to estimate the economic burden of MS patients, treated with dimethyl fumarate (DMF) in Greece....
Economic evaluation of an add-on module to reduce intrusive suicidal Mental images in patients with depressive symptoms [0.03%]
用于具有抑郁症状患者的减少侵入性自杀心理图像的附加模块的经济评估
Jaël van Bentum,Ben Wijnen,Nathan Bachrach et al.
Jaël van Bentum et al.
Background: Previous research demonstrated the effectiveness of an add-on module in reducing intrusive suicidal mental images in patients with elevated depression symptoms indicative of a depressive disorder. This study a...
Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer [0.03%]
替西妥珠单抗治疗转移或复发性宫颈癌的疗效和成本效益分析
María Del Pilar Briceño-Casado,Adrián Sánchez Vegas,Emilio Jesús Alegre-Del-Rey et al.
María Del Pilar Briceño-Casado et al.
Objective: To evaluate the cost-effectiveness of tisotumab vedotin (TV) versus single-agent chemotherapy in patients with recurrent or metastatic cervical cancer (r/mCC) after failure of first-line treatment, from the per...
Cost-effectiveness analysis of larotrectinib vs standard of care for treatment of metastatic NTRK fusion colorectal cancer [0.03%]
拉罗替尼对比标准治疗用于转移性NTRK融合结直肠癌患者的成本效益分析
Lu Zhong,Mei Dong,Tong Liu
Lu Zhong
Background: This study evaluates the cost-effectiveness of larotrectinib compared to the standard of care for treating metastatic NTRK fusion colorectal cancer (CRC) from the perspective of healthcare payers in China. ...
Optimizing COPD management in Latin America: a cost-effectiveness analysis of FF/UMEC/VI in Colombia [0.03%]
优化拉丁美洲COPD治疗方案：从哥伦比亚开始进行FF/UMEC/VI治疗的成本效益分析
Jefferson Antonio Buendía,Diana Guerrero Patiño
Jefferson Antonio Buendía
Background: Chronic obstructive pulmonary disease (COPD) imposes a substantial clinical and economic burden in Colombia, particularly among older adults. Despite widespread use of dual therapy, many patients remain at hig...